Quadruple Screening Test

The quadruple screening test, also referred to as the quadruple marker test, is a routine blood test administered between 14 and 20 weeks of pregnancy. Its primary purpose is to assess the likelihood of certain genetic conditions in the fetus.

Pioneers in Prenatal Care

Medicover Hospitals provides comprehensive prenatal care in the second trimester, including the Quadruple Screening Test and other screenings. With advanced genetic labs using next-gen sequencing, we deliver precise results. Trust us for the best Quadruple Screening Test near you, ensuring peace of mind for expectant parents.

What Does It Screen For?

This test evaluates four biochemical markers to estimate the probability of various conditions, including Down syndrome, Trisomy 18, Edwards syndrome, neural tube defects, and abdominal wall defects.

How Quadruple Screening Test Works

The quadruple screening test doesn't provide a diagnosis but helps identify any potential increased risk of congenital disorders. If the results are abnormal, further diagnostic tests may be recommended.

Procedure and Timing

The test, performed by a phlebotomist, involves a simple blood draw from the expectant mother. For the most accurate results, it's typically conducted between weeks 16 and 18 of pregnancy.

Process Overview

Medicover ensures a seamless process from sample collection to genetic counseling, empowering parents with accurate information. With advanced prenatal screening, we prioritize the well-being of both mothers and their unborn children.